Mometasone furoate 110mcg/inh, 220mcg/inh; pwd for oral inhalation; with dose counter. Maintain regular regimen. Prescribe a short-acting, inhaled β2-agonist for acute symptoms. Re-evaluate ...
April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...
The 110mcg strength of Asmanex Twisthaler (mometasone furoate inhalation powder, from Schering-Plough), an inhaled corticosteroid, is now available for the maintenance treatment of asthma in patients ...
Asmanex Twisthaler has been launched by Schering-Plough as therapy in the control and management of mild, moderate or severe persistent asthma in Asmanex Twisthaler has been launched by ...
June 28, 2010 — The US Food and Drug Administration (FDA) has approved Dulera (Merck & Co, Inc) inhalation aerosol containing a combination of mometasone furoate and formoterol fumarate dihydrate for ...
ASMANEX provides physicians with a new treatment option to help manage children's asthma as back-to-school season approaches. KENILWORTH, N.J., Aug. 19 /PRNewswire ...
Asmanex Twisthaler from Glenmark aims to make daily asthma control almost automatic with a breath-activated powder inhaler and once-daily dosing. Where does it shine in real life - and where do ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results